Bedside Snapshot
- Normal Result
- Dipstick negative (under about 15 mg/dL); UPCR <0.15 mg/mg (<150 mg/g); 24-hour protein <150 mg/day.
- Significant Result
- Dipstick 1+ or more (≥30 mg/dL), or UPCR ≥0.15 mg/mg (≥150 mg/g), confirmed on repeat. Nephrotic range is UPCR >3.5 g/g.
- Positive Suggests
- Diabetic or hypertensive kidney disease (albumin)
- Glomerulonephritis or nephrotic syndrome
- Myeloma light chains (overflow)
- Transient causes: fever, exercise, orthostasis
- Negative Does Not Exclude
- Light-chain (Bence Jones) proteinuria: the dipstick misses it. Order urine electrophoresis, immunofixation and serum free light chains when myeloma is suspected.
- Act Now If
- Nephrotic range with edema, AKI or hypertension; or pregnancy with BP ≥160/110 or severe features: urgent escalation; treat severe-range BP per obstetric protocol.
- Watch Out For
- Concentrated urine or contamination can give a false-positive dipstick. Repeat on a first-morning sample and quantify before labeling proteinuria.
Reference & Critical Ranges
Reference ranges
| Population | Conventional | SI | Notes |
|---|---|---|---|
| Adult, random urine (dipstick) | Negative (under about 15 mg/dL) | Under about 0.15 g/L | Screening only; not a quantity |
| Adult, 24-hour urine protein | <150 mg/day | <0.15 g/day | Gold standard quantity; check collection with creatinine |
| Adult, UPCR | <0.15 mg/mg (<150 mg/g) | <17 mg/mmol creatinine | Approximates 24-hour protein in g/day |
| Adult, ACR | <30 mg/g | <3.4 mg/mmol | Preferred for albuminuria and diabetic screening |
| Pregnancy | Not a normal-range category. ACOG proteinuria criteria: 300 mg/24 h or more, UPCR 0.3 mg/mg or more, or dipstick reading only when quantitative testing is unavailable | — | See Special Populations |
| Children | Use pediatric reference values; adult thresholds do not apply | — | See Special Populations |
Severity & critical values
| Dipstick result | Approximate protein (mg/dL) | Meaning |
|---|---|---|
| Negative | Under about 15 | Normal screen |
| Trace | About 15–30 | Borderline; repeat on a first-morning sample |
| 1+ | 30 | Significant; quantify with UPCR or ACR |
| 2+ | 100 | Significant; quantify with UPCR or ACR |
| 3+ | 300 | Heavy proteinuria; nephrotic range possible |
| 4+ | ≥2,000 | Very heavy; nephrotic range likely |
| Level | ACR mg/g (mg/mmol) | UPCR mg/g (mg/mmol) | Meaning |
|---|---|---|---|
| Normal (A1) | <30 (<3.4) | <150 (<17) | Normal or minimally increased |
| Moderately increased (A2) | 30–300 (3.4–34) | 150–500 (17–57) | Microalbuminuria or moderate proteinuria |
| Severely increased (A3) | >300 (>34) | >500 (>57) | Heavy albuminuria or proteinuria; CKD likely if persistent |
| Critical | — | >3,500 (>396) | Nephrotic range (typical threshold; lab-specific) |
Conversion: To go from mg/g creatinine to mg/mmol creatinine, multiply by 0.113. UPCR in mg/mg approximates 24-hour protein in g/day. KDIGO prints rounded SI values. For ACR, that's <3, 3–30 and >30 mg/mmol. For UPCR, it's <15, 15–50 and >50 mg/mmol.
Normal spot UPCR: <0.15 mg/mg (<150 mg/g). Match the units to your lab report. mg/mg and g/g are the same value.
Causes of Abnormal Results
Positive result
| Cause | Clinical clue |
|---|---|
| Diabetic kidney disease (glomerular) | Albuminuria in long-standing diabetes; ACR is the test of choice |
| Glomerulonephritis (IgA, membranous, FSGS, minimal change) | Nephrotic pattern (edema, low albumin, high cholesterol) or nephritic pattern (hematuria, RBC casts, hypertension) |
| Lupus nephritis, amyloidosis (glomerular) | Systemic disease signs; sediment with RBC casts or hematuria in lupus |
| Preeclampsia (glomerular, pregnancy) | New hypertension at or after 20 weeks; proteinuria may be absent |
| Multiple myeloma (overflow, light chains) | Anemia, bone pain, hypercalcemia, AKI; dipstick can be negative |
| Tubular disease (ATN, interstitial nephritis, Fanconi) | AKI, drug exposure, WBC casts or pyuria; low-molecular-weight proteins |
| Heme pigments (hemoglobin, myoglobin) | Dark urine after hemolysis or crush injury; positive blood with few or no RBCs; check CK |
| Transient or functional | Fever, intense exercise, dehydration, orthostasis; first-morning sample negative |
False positive vs true positive
| Cause | Clue and fix |
|---|---|
| Concentrated urine | High specific gravity can give a trace or 1+ read; repeat with UPCR |
| Alkaline urine | pH above about 7–8; repeat on fresh sample |
| Blood or heme pigments | Microscopy shows RBCs or heme pigment; quantify with UPCR |
| Pyuria (heavy leukocyturia) | Can cause a trace positive; check microscopy for WBCs and repeat on a clean sample |
| Chlorhexidine contamination | Antiseptic on the collection site; repeat with a clean-catch sample |
| Quaternary ammonium contamination | Benzalkonium chloride antiseptic on the collection site |
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Repeat on a first-morning void and rule out fever, exercise, dehydration or contamination. Orthostatic proteinuria disappears on a supine first-morning sample.
- How much? Quantify with spot UPCR (mg/mg) or ACR (mg/g). Spot UPCR is acceptable in pregnancy; use a 24-hour collection when the spot result is discordant with the clinical picture.
- What kind? Dipstick and ACR detect mainly albumin. Negative dipstick with suspected myeloma requires urine protein electrophoresis with immunofixation and serum free light chains.
- Glomerular or tubular? Compare albumin-predominant proteinuria with low-molecular-weight proteins and the urine sediment (RBC casts, WBC casts, fatty casts).
- Look for systemic clues: serum albumin, creatinine and eGFR, blood pressure, glucose and HbA1c, lipids, CK if heme-positive urine, and pregnancy status.
- Classify and escalate: KDIGO 2024 CKD staging uses eGFR (G) and albuminuria (A) categories, confirmed on repeat testing over 3 months or more. Nephrotic range or severe pregnancy features need urgent escalation.
Decision table
| Pattern | Suggests |
|---|---|
| ACR 30–300 mg/g in diabetes or hypertension | Early diabetic or hypertensive kidney disease; repeat and stage CKD |
| UPCR >3.5 g/g with low albumin and edema | Nephrotic syndrome; urgent nephrology referral |
| Proteinuria with RBC casts or hematuria and hypertension | Glomerulonephritis (nephritic pattern); urgent evaluation |
| Dipstick negative, high suspicion of myeloma | Light-chain proteinuria; order UPEP, immunofixation and serum free light chains |
| Positive on daytime (upright) sample; negative on first-morning sample | Orthostatic or transient proteinuria |
Management Priorities
Emergency: Pregnancy or postpartum with severe-range blood pressure
- Confirm severity: Blood pressure ≥160 mmHg systolic or ≥110 mmHg diastolic, persisting 15 minutes or more. Other severe features (new neurologic symptoms, new headache or visual change, shortness of breath or pulmonary edema, epigastric or right-upper-quadrant pain) add urgency; platelets below 100,000, creatinine above 1.1 mg/dL or doubled, and transaminases twice normal require laboratory confirmation.
- Treat the blood pressure: Treat within 30–60 minutes of confirmed severe-range blood pressure per ACOG, with antihypertensives per obstetric protocol and medical direction; see the labetalol page.
- Seizure prevention: Magnesium sulfate per obstetric protocol for severe features; see the magnesium sulfate page.
- Escalate: Transport to obstetric capability; do not delay for the urine result. Preeclampsia can present up to 6 weeks postpartum.
Definitive care & disposition
- Nephrotic syndrome: Urgent nephrology referral for biopsy-directed therapy and immunosuppression decisions; monitor for thrombosis and infection.
- Glomerulonephritis with AKI: Nephrology referral; check creatinine, potassium and urine sediment.
- Diabetic and hypertensive kidney disease: Per KDIGO 2024: renin-angiotensin system blockade for CKD with severely increased albuminuria (with or without diabetes) and for moderately increased albuminuria with diabetes (a weaker suggestion without diabetes); SGLT2 inhibitor for eligible patients (eGFR 20 or above with ACR 200 mg/g or above, or heart failure); finerenone in type 2 diabetes with albuminuria.
- Myeloma suspicion: Hematology referral; urine electrophoresis and serum free light chains.
Drug choice and doses follow local protocols, medical direction and institutional policy.
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Neonates & infants | Urine collection is difficult and pediatric reference values apply | Use pediatric reference values and a collection with creatinine; defer to pediatric nephrology |
| Children & adolescents | Orthostatic proteinuria is common | Repeat on a first-morning sample before workup; persistent proteinuria needs evaluation with pediatric nephrology input |
| Pregnancy | Proteinuria is no longer required for preeclampsia diagnosis per ACOG 2020 | New hypertension at or after 20 weeks with end-organ signs is preeclampsia even without proteinuria; treat per obstetric protocol. ACE inhibitors and ARBs are contraindicated in pregnancy |
| Older adults | Low-grade albuminuria is more common | Interpret with eGFR and blood pressure; a single abnormal result needs repeat testing |
| CKD / dialysis | Proteinuria is a staging and treatment target | Quantify every 1–4 times per year by CKD stage per KDIGO 2024; dialysis patients need individualized assessment |
| Liver disease | Low albumin from liver failure can mimic nephrotic edema | Check urine protein quantity before attributing edema to nephrotic syndrome |
| Diabetes | Albuminuria is an early sign of kidney injury | Screen with ACR and eGFR: type 2 at diagnosis, type 1 after 5 years of diabetes per ADA 2026, then at least yearly |
Interfering Factors & Pitfalls
Collection & handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Dilute urine | False − | Protein falls below dipstick detection threshold | Check specific gravity; use UPCR on a concentrated sample |
| Concentrated urine | False + | High specific gravity intensifies dipstick reaction | Repeat on first-morning sample; quantify |
| Vaginal secretions, semen or menstrual blood | False + | Contamination adds protein and cells | Clean-catch technique; repeat if discordant |
| Incomplete 24-hour collection | Wrong quantity | Missed voids distort the total | Check creatinine excretion to judge completeness |
| Delayed processing at room temperature | Variable | Specimen changes over time | Process promptly or refrigerate per lab |
Medications & supplements
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| NSAIDs | ↑ proteinuria | Associated with minimal change disease and acute interstitial nephritis | Review use; watch creatinine |
| Lithium | ↑ proteinuria | Chronic tubulointerstitial disease | Monitor creatinine and urine protein |
| Gold, penicillamine | ↑ proteinuria | Membranous nephropathy | Monitor urine protein |
| ACE inhibitors and ARBs | ↓ proteinuria | Lower intraglomerular pressure | Expect creatinine rise up to 30% per KDIGO 2024; check potassium. Contraindicated in pregnancy (fetal toxicity boxed warning) |
| SGLT2 inhibitors | ↓ albuminuria | Renoprotective effect in diabetes and CKD | Not a reason to skip the workup |
Physiologic & biologic
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Fever, exercise, dehydration | ↑ transient | Temporary changes in glomerular or tubular handling | Repeat when well-hydrated and afebrile |
| Orthostatic posture | ↑ upright only | Benign in adolescents and young adults | Use first-morning supine sample |
| Heme pigments (hemoglobin, myoglobin) | False + | Gross hematuria or hemoglobinuria can add protein and raise the read; myoglobinuria is typically blood-positive with little protein signal | Confirm with microscopy, CK and UPCR |
Assay & device-specific
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Dipstick sensitivity to albumin only | False − for light chains | Light chains are not detected by standard dipstick | Use UPEP, immunofixation, serum free light chains |
| Dipstick for microalbuminuria | False − at low albumin | Dipstick is not sensitive enough for ACR 30–300 mg/g | Use ACR |
| Strip grading | Variable grades | Protein cut-offs differ by manufacturer | Use the lab's reference, not this table |
Common misinterpretations
- A negative dipstick won't clear light-chain proteinuria. The strip misses it.
- One positive dipstick doesn't make CKD. Persistence for 3 months or more is what counts.
- An early creatinine rise after starting an ACE inhibitor or ARB is no reason to stop it, as long as it stays in the expected range.
- You don't need proteinuria to diagnose preeclampsia. A negative urine test doesn't rule it out.
Physiology & Test Basics
What it measures
This page covers protein excreted in urine. Four tools measure it: dipstick, spot protein-to-creatinine ratio (UPCR), 24-hour collection and albumin-to-creatinine ratio (ACR). Albumin-specific testing lives on the albuminuria pages. Here, the focus is total urine protein and the screening methods.
Physiology & regulation
- The glomerular capillary wall holds back most plasma protein. A small amount gets through.
- The proximal tubule reclaims most of the filtered low-molecular-weight protein.
- Proteinuria comes from three places: a leakier glomerulus, a tubule that reclaims less, or overflow of abnormal proteins.
How it is measured
The dipstick uses a random urine sample. UPCR and ACR use a spot sample, and a first-morning sample is preferred when orthostatic proteinuria is suspected. Total protein comes from a 24-hour urine collection with a creatinine check. UPCR and ACR need a lab. The dipstick is point-of-care.
Why it matters
Proteinuria is a marker of kidney injury. It predicts progression to end-stage kidney disease and cardiovascular risk. In the emergency setting, heavy proteinuria in pregnancy or nephrotic syndrome changes the disposition.
Clinical Pearls
References
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117–S314. https://kdigo.org/guidelines/ckd-evaluation-and-management/
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. (2021). KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4S):S1–S276. https://doi.org/10.1016/j.kint.2021.05.021
- American Diabetes Association Professional Practice Committee. (2026). Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026, Section 11. Diabetes Care, 49(Suppl. 1). https://doi.org/10.2337/dc26-S011
- American College of Obstetricians and Gynecologists. (2020). Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin No. 222. Obstetrics & Gynecology. https://doi.org/10.1097/AOG.0000000000003891
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.